Erasca, Inc. (ERAS)
Nasdaq: ERAS · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2019
Who owns Erasca, Inc.
As filed with the SECHolders of 5% or more
5
Jonathan E. Lim holds 10.4% of Common Stock, $0.0001 par value per share, as its SCHEDULE 13G/A filed Aug 14, 2026 says.
Directors and officers
12
report now, of 17 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Jonathan E. Lim
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, $0.0001 par value per share
T. Rowe Price Investment Management, Inc.
SCHEDULE 13G/A · filed May 15, 2026 · COMMON STOCK · 5.7% in Feb 17, 2026
Venrock Healthcare Capital Partners III, L.P.
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share
Frazier Life Sciences Public Fund, L.P.
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, $0.0001 par value per share · 8% in May 15, 2025
RTW Investments, LP
SCHEDULE 13G · filed May 15, 2026 · Common Stock, $0.0001 par value
Logos Global Management LP
SCHEDULE 13G/A · filed Nov 14, 2025 · Common Stock · reported falling below 5%, from 5.3% in Aug 14, 2025
Novartis Pharma AG
SCHEDULE 13G/A · filed Feb 12, 2025 · Common stock, par value $0.0001 per share · reported falling below 5%
Paradigm BioCapital Advisors LP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.3% in Jan 14, 2026
Suvretta Capital Management, LLC
SCHEDULE 13G/A · filed May 12, 2026 · Common Stock, $0.0001 par value per share · reported falling below 5%, from 5.1% in Aug 13, 2025
What ERAS reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Asana Merger Agreement
A company bought · acquisition · owns, named in the 10-K filed Mar 12, 2026
Insider tradesForm 4
3sales
0purchases
3sales on a scheduled plan
2people selling
$2.3Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 28 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Garner Ebun | Chief Legal Officer | 2 | $2.0M | 2 | 0 | $0 |
| Morris Shannon | Chief Medical Officer | 1 | $300,000 | 1 | 0 | $0 |